Form 4: Astrana Health COO Chandan Basho Reports Share Surrender for Tax Obligations

Chandan Basho, COO and CFO of Astrana Health, surrendered 7,051 shares to cover tax obligations related to vesting restricted stock on May 16, 2024.

Summary

• On May 16, 2024, Chandan Basho, the COO and CFO of Astrana Health, surrendered 7,051 shares of common stock to cover tax withholding obligations.
• The shares were surrendered at a price of $41.13 per share.
• Following the transaction, Basho directly owns 151,232 shares of Astrana Health, which includes unvested restricted stock and restricted stock units.
• The unvested restricted stock will vest in installments between April 2025 and May 2027, subject to continuous employment.
• The restricted stock units will vest in semi-annual installments beginning on October 2, 2024, also subject to continuous employment.

Sentiment

Score: 5

Explanation: This is a neutral event; a routine transaction related to tax obligations. It doesn't inherently reflect positive or negative sentiment towards the company.

Industry Context

This is a routine Form 4 filing, reflecting a common practice of executives surrendering shares to cover tax obligations upon the vesting of restricted stock. It doesn't necessarily indicate a change in the executive's confidence in the company.

Comparison to Industry Standards

• Share surrenders for tax obligations are a standard practice among publicly traded companies.
• The amount of shares surrendered is proportional to the executive's tax liability and the value of the vested stock.
• Similar transactions are regularly reported by executives at comparable healthcare companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders, as it is a standard practice and does not significantly alter the executive's overall holdings.
• Employees are not directly impacted by this transaction.

Key Dates